Early hematopoietic zinc finger protein prevents tumor cell recognition by natural killer cells

Journal of Immunology

Volumn 182, Issue 8, 2009, Pages 4529-4537

  La Rocca, Rosanna ^a   Fulciniti, Mariateresa ^a   Lakshmikanth, Tadepally ^a,e   Mesuraca, Maria ^a   Ali, Talib Hassan ^a   Mazzei, Valerio ^a   Amodio, Nicola ^a   Catalano, Lucio ^b   Rotoli, Bruno ^b   Ouerfelli, Ouathek ^c   Grieco, Michele ^a   Gulletta, Elio ^a   Bond, Heather M ^a   Morrone, Giovanni ^a   Ferrone, Soldano ^d   Carbone, Ennio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; EARLY HEMATOPOIETIC ZINC FINGER PROTEIN; HLA ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; DNA BINDING PROTEIN; LIGAND; ZINC FINGER PROTEIN 521, HUMAN;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MULTIPLE MYELOMA; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR CELL; UPREGULATION; UTERINE CERVIX CARCINOMA; ANIMAL; ANTIGEN PRESENTATION; CELL LINE; CERCOPITHECUS; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; METABOLISM; NEOPLASM; TRANSGENE;

ANIMALS; ANTIGEN PRESENTATION; CELL LINE; CERCOPITHECUS AETHIOPS; DNA-BINDING PROTEINS; DOWN-REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LIGANDS; NEOPLASMS; TRANSCRIPTION, GENETIC; TRANSGENES; UP-REGULATION;

EID: 65249110569     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802109     Document Type: Article

References (45)

1. Bond, H. M., M. Mesuraca, E. Carbone, P. Bonelli, V. Agosti, N. Amodio, G. De Rosa, M. Di Nicola, A. M. Gianni, M. A. Moore, et al. 2004. Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells. Blood 103: 2062-2070.
2. Bond, H. M., M. Mesuraca, N. Amodio, T. Mega, D. Pelaggi, V. Agosti, D. Fanello, L. Bullinger, M. Grieco, M. A. S. Moore, et al. 2008. Early hematopoietic zinc finger protein/zinc finger protein 521 (EHZF/ZNF521): a candidate regulator of diverse immature cells. Int. J. Biochem. Cell Biol. 40: 848-854.
3. Mullighan, C. G., S. Goorha, I. Radtke, C. B. Miller, E. Coustan-Smith, J. D. Dalton, K. Girtman, S. Mathew, J. Ma, S. B. Pounds, et al. 2007. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446: 758-764.
4. Carbone, E., P. Neri, M. Mesuraca, M. T. Fulciniti, T. Otsuki, D. Pende, V. Groh, T. Spies, G. Pollio, D. Cosman, et al. 2005. HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells. Blood 105: 251-258. (Pubitemid 40053090)
5. Siegler, U., C. P. Kalberer, P. Nowbakht, S. Sendelov, S. Meyer-Monard, and A. Wodnar-Filipowicz. 2005. Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice. Leukemia 19: 2215-2222. (Pubitemid 41741617)
6. Frohn, C., M. Höppner, P. Schlenke, H. Kirchner, P. Koritke, and J. Luhm. 2002. Antimyeloma activity of natural killer lymphocytes. Br. J. Haematol. 119: 660-664. (Pubitemid 35366205)
7. Costello, R. T., C. Fauriat, S. Sivori, E. Marcenaro, and D. Olive. 2004. NK cells: innate immunity against hematological malignancies? Trends Immunol. 25: 328-333. (Pubitemid 38610357)
8. + B cells. J. Immunol. 167: 6132-6139.
9. Carbone, E., G. Terrazzano, G. Ruggiero, D. Zanzi, A. Ottaiano, C. Manzo, K. Kärre, and S. Zappacosta. 1999. Recognition of autologous dendritic cells by human NK cells. Eur. J. Immunol. 29: 4022-4029.
10. Carbone, E., G. Terrazzano, A. Melián, D. Zanzi, L. Moretta, S. Porcelli, K. Kärre, and S. Zappacosta. 2000. Inhibition of human NK cell-mediated killing by CD1 molecules. J. Immunol. 164: 6130-6137. (Pubitemid 30408789)
11. Martín-Fontecha, A., E. Assarsson, E. Carbone, K. Kärre, and H. G. Ljunggren. 1999. Triggering of murine NK cells by CD40 and CD86 (B7-2). J. Immunol. 162: 5910-5916. (Pubitemid 29314945)
12. Carbone, E., G. Ruggiero, G. Terrazzano, C. Palomba, C. Manzo, S. Fontana, H. Spits, K. Kärre, and S. Zappacosta. 1997. A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J. Exp. Med. 185: 2053-2060. (Pubitemid 27265988)
13. Farag, S. S., T. A. Fehniger, L. Ruggeri, A. Velardi, and M. A. Caligiuri. 2002. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 100: 1935-1947.
14. H1 priming. Nat. Immunol. 5: 1260-1265.
15. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47: 187-376.
16. Bottino, C., L. Moretta, D. Pende, M. Vitale, and A. Moretta. 2004. Learning how to discriminate between friends and enemies, a lesson from natural killer cells. Mol. Immunol. 41: 569-575. (Pubitemid 38824614)
17. Bottino, C., L. Moretta, D. Pende, M. Vitale, and A. Moretta. 2001. Human natural killer cell receptors and co-receptors. Immunol. Rev. 181: 203-214. (Pubitemid 32703408)
18. Long, E. O. 1999. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17: 875-904. (Pubitemid 29241142)
19. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19: 197-223. (Pubitemid 32368034)
20. Pende, D., S. Parolini, A. Pessino, S. Sivori, R. Augugliaro, L. Morelli, E. Marcenaro, L. Accame, A. Malaspina, R. Biassoni, et al. 1999. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 190: 1505-1516.
21. Gonzalez, S., V. Groh, and T. Spies. 2006. Immunobiology of human NKG2D and its ligands. Curr. Top. Microbiol. Immunol. 298: 121-138. (Pubitemid 41508788)
22. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stressinducible MICA. Science 285: 727-729. (Pubitemid 129505074)
23. Sutherland, C. L., N. J. Chalupny, and D. Cosman. 2001. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. Immunol. Rev. 181: 185-192.
24. Pende, D., C. Bottino, R. Castriconi, C. Cantoni, S. Marcenaro, P. Rivera, G. M. Spaggiari, A. Dondero, B. Carnemolla, N. Reymond, et al. 2005. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis. Mol. Immunol. 42: 463-469. (Pubitemid 39655955)
25. Qin, X. F., D. S. An, I. S. Chen, and D. Baltimore. 2003. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. USA 100: 183-188.
26. Pende, D., P. Rivera, S. Marcenaro, C. C. Chang, R. Biassoni, R. Conte, M. Kubin, D. Cosman, S. Ferrone, L. Moretta, et al. 2002. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res. 62: 6178-6186. (Pubitemid 35244469)
27. Bottino, C., R. Castriconi, D. Pende, P. Rivera, M. Nanni, B. Carnemolla, C. Cantoni, J. Grassi, S. Marcenaro, N. Reymond, et al. 2003. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J. Exp. Med. 198: 557-567. (Pubitemid 37040390)
28. Seliger, B., T. Cabrera, F. Garrido, and S. Ferrone. 2002. HLA class I antigen abnormalities and immune escape by malignant cells. Semin. Cancer Biol. 12: 3-13. (Pubitemid 34087893)
29. Pellegrino, M. A., A. K. Ng, C. Russo, and S. Ferrone. 1982. Heterogeneous distribution of the determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules. Transplantation 34: 18-23.
30. Stam, N. J., T. M. Vroom, P. J. Peters, E. B. Pastoors, and H. L. Ploegh. 1990. HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in Western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int. Immunol. 2: 113-125.
31. 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide. J. Immunol. 171: 1918-1926.
32. Wang, X., M. Campoli, H. S. Cho, T. Ogino, N. Bandoh, J. Shen, S. Y. Hur, T. Kageshita, and S. Ferrone. 2005. A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections. J. Immunol. Methods 299: 139-151. (Pubitemid 40725931)
33. Ogino, T., X. Wang, S. Kato, N. Miyokawa, Y. Harabuchi, and S. Ferrone. 2003. Endoplasmic reticulum chaperone-specific monoclonal antibodies for flow cytometry and immunohistochemical staining. Tissue Antigens 62: 385-393. (Pubitemid 37338878)
34. Bandoh, N., T. Ogino, H. S. Cho, S. Y. Hur, J. Shen, X. Wang, S. Kato, N. Miyokawa, Y. Harabuchi, and S. Ferrone. 2005. Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies. Tissue Antigens 66: 185-194. (Pubitemid 41243306)
35. McGinnes, K., C. G. Marks, and R. Penny. 1986. A fluorescence NK assay using flow cytometry. J. Immunol. Methods 86: 7-15. (Pubitemid 16187281)
36. Nisticò, P., R. Mortarini, B. L. De Monte, A. Mazzocchi, M. Mariani, F. Malavasi, G. Parmiani, P. G. Natali, and A. Anichini. 1992. Cell retargeting by bispecific monoclonal antibodies: evidence of bypass of intratumor susceptibility to cell lysis in human melanoma. J. Clin. Invest. 90: 1093-1099.
37. + cytotoxic T lymphocyte clone which specifically recognizes HLA-A2 molecule. Scand. J. Immunol. 35: 487-494.
38. Mazzocchi, A., A. Anichini, C. Castelli, M. Sensi, F. Poli, C. Russo, and G. Parmiani. 1990. T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: evidence with a single T cell clone. Cancer Immunol. Immunother. 32: 13-21.
39. Ikeda, H., B. Lethé, F. Lehmann, N. van Baren, J. F. Baurain, C. de Smet, H. Chambost, M. Vitale, A. Moretta, T. Boon, and P. G. Coulie. 1997. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6: 199-208. (Pubitemid 27145564)
40. Bakker, A. B., J. H. Phillips, C. G. Figdor, and L. L. 1998. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, γδ T cells, and antigen-specific CTL. J. Immunol. 160: 5239-5245.
41. Seliger, B., M. J. Maeurer, and S. Ferrone. 2000. Antigen-processing machinery breakdown and tumor growth. Immunol. Today 21: 455-464.
42. Yewdell, J. 2002. To DRiP or not to DRiP: generating peptide ligands for MHC class I molecules from biosynthesized proteins. Mol. Immunol. 39: 139-146. (Pubitemid 35013507)
43. Marincola, F. M., E. M. Jaffee, D. J. Hicklin, and S. Ferrone. 2000. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv. Immunol. 74: 181-273.
44. Ferrone, S., and F. M. Marincola. 1995. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today 16: 487-494.
45. Nasca, R., and E. Carbone. 1999. Natural killer cells as potential tools in melanoma metastatic spread control. Oncol. Res. 11: 339-343.